Maria Horga

Chief Tech/Sci/R&D Officer bei ATEA PHARMACEUTICALS, INC.

Vermögen: 103 683 $ am 31.03.2024

55 Jahre

Health Technology

Commercial Services

Consumer Services

Aktive Positionen von Maria Horga

Unternehmen	Position	Beginn	Ende
ATEA PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	01.10.2020	-
ATEA PHARMACEUTICALS, INC.	Corporate Officer/Principal	01.08.2020	01.10.2020

Unternehmen	Position	Beginn	Ende
Biohaven Pharmaceuticals, Inc. Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT.	Corporate Officer/Principal	01.10.2019	01.08.2020
Roche Innovation Center	Corporate Officer/Principal	01.07.2017	01.08.2019
F. Hoffmann-La Roche Ltd. F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.	Corporate Officer/Principal	01.01.2012	01.01.2016
BRISTOL-MYERS SQUIBB COMPANY	Chief Tech/Sci/R&D Officer	-	-

University of Santander

Doctorate Degree

International

Operativ

Corporate Officer/Principal	4
Chief Tech/Sci/R&D Officer	2
Doctorate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
ATEA PHARMACEUTICALS, INC.	Health Technology

Private Unternehmen	3
F. Hoffmann-La Roche Ltd. F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.	Health Technology
Biohaven Pharmaceuticals, Inc. Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT.	Commercial Services
Roche Innovation Center